Li Long
Corporate Officer/Principal presso KEZAR LIFE SCIENCES, INC.
Posizioni attive di Li Long
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | - | - |
Storia della carriera di Li Long
Precedenti posizioni note di Li Long
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | - | - |
Formazione di Li Long
| McGill University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Canada | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Li Long
- Esperienza
